Opus Global Nyrt operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Opus Global Nyrt with three other
pharmaceutical manufacturers in Europe:
sales of 132.41 million Euro [US$154.14 million]
Eckert & Ziegler Strahlen- und Medizinte
(138.63 million Euro [US$161.39 million]
of which 62%
was Isotope Products), and
Dottikon ES Holding AG
based in Switzerland
(151.75 million Swiss Francs [US$151.90 million]
of which 89%
was Pharma Products).
Sales increased substantially in 2017:
During the year ended December of 2017, sales at
Opus Global Nyrt were 42.55 billion Hungarian Forints (US$152.76 million).
increase of 177.8%
versus 2016, when the company's sales were 15.31 billion Hungarian Forints.